Related Experiment Video
Updated: Feb 21, 2026
08:55
Methods of Ex Situ and In Situ Investigations of Structural Transformations: The Case of Crystallization of Metallic Glasses
Published on: June 7, 2018
9.0K
Pharmacy Practice and Education in the Czech Republic
Petr Nachtigal1, Tomáš Šimůnek2, Jeffrey Atkinson3
1Faculty of Pharmacy, Charles University, Akademika Heyrovského 1203, Hradec Králové 500 05, Czech Republic. Petr.Nachtigal@faf.cuni.cz.
Pharmacy (Basel, Switzerland)
|October 10, 2017
Summary
The PHARMINE survey details Czech Republic pharmacy education, covering its five-year master's degree, mandatory registration, and community pharmacy practice. It aligns with EU directives, with specializations offered post-graduation.
Area of Science:
- Pharmacy Education
- Pharmaceutical Practice
- Health Policy
Background:
- The PHARMINE project assessed pharmacy education, practice, and legislation harmonization across the European Union.
- This paper focuses on the Czech Republic's pharmacy sector as part of the PHARMINE survey.
Purpose of the Study:
- To present the findings of the PHARMINE survey on pharmacy education, training, and practice in the Czech Republic.
- To evaluate the alignment of Czech pharmacy standards with European Union (EU) directives.
Main Methods:
- A survey was conducted on pharmacy education, practice, and legislation in Czech Republic.
- Data collection involved reviewing educational structures, professional registration, and pharmacy ownership models.
Main Results:
- Czech pharmacists complete a five-year Master's degree (Mgr.) and must register with the Czech Chamber of Pharmacists.
- Community pharmacies offer Rx, OTC, and diagnostic services; ownership is not exclusive to pharmacists, with many in chains.
- Pharmacy education is a five-year integrated master's course including a six-month traineeship, compliant with EU directives.
Conclusions:
- Czech pharmacy education and practice are structured to align with EU requirements.
- Postgraduate specialization is managed by the Czech Chamber of Pharmacists, not integrated into university curricula.
Related Concept Videos
01:19Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence
199
Pharmaceutical products contain more than just the active drug; they also contain various excipients such as binders, solubilizers, stabilizers, preservatives, and other elements. In some cases, impurities or contaminants might be present. Traditionally, quality control in pharmaceuticals has primarily focused on the analysis of the active drug, often overlooking the impact of these additional components. The recent issue with heparin contamination by over-sulfated chondroitin sulfate, a...
199
01:26Pharmaceutical Poisoning: Potential Scenarios
22
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
22
01:03Drug Control Governance: Regulatory Bodies and Their Impact
594
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
594
01:22Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
221
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
221
01:28Dosage Regimens: Designs and Approaches
367
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
367
01:27Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
197
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
197